196 related articles for article (PubMed ID: 33782502)
21. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
22. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
Weir AP; Morgan JE; Davies KE
Neuromuscul Disord; 2004 Jan; 14(1):19-23. PubMed ID: 14659408
[TBL] [Abstract][Full Text] [Related]
23. MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice.
Gallot YS; Straughn AR; Bohnert KR; Xiong G; Hindi SM; Kumar A
Hum Mol Genet; 2018 Oct; 27(19):3449-3463. PubMed ID: 30010933
[TBL] [Abstract][Full Text] [Related]
24. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
25. The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice.
Stupka N; Gregorevic P; Plant DR; Lynch GS
Acta Neuropathol; 2004 Apr; 107(4):299-310. PubMed ID: 14727129
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy.
Verma M; Shimizu-Motohashi Y; Asakura Y; Ennen JP; Bosco J; Zhou Z; Fong GH; Josiah S; Keefe D; Asakura A
PLoS Genet; 2019 Dec; 15(12):e1008468. PubMed ID: 31877123
[TBL] [Abstract][Full Text] [Related]
27. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
28. Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy.
Wehling-Henricks M; Li Z; Lindsey C; Wang Y; Welc SS; Ramos JN; Khanlou N; Kuro-O M; Tidball JG
Hum Mol Genet; 2016 Jun; 25(12):2465-2482. PubMed ID: 27154199
[TBL] [Abstract][Full Text] [Related]
29. Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis.
Wang L; Zhou L; Jiang P; Lu L; Chen X; Lan H; Guttridge DC; Sun H; Wang H
Mol Ther; 2012 Jun; 20(6):1222-33. PubMed ID: 22434133
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a novel microRNA, miR-188, elevated in serum of muscular dystrophy dog model.
Shibasaki H; Imamura M; Arima S; Tanihata J; Kuraoka M; Matsuzaka Y; Uchiumi F; Tanuma SI; Takeda S
PLoS One; 2019; 14(1):e0211597. PubMed ID: 30699200
[TBL] [Abstract][Full Text] [Related]
31. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Charan RA; Hanson R; Clemens PR
FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
[TBL] [Abstract][Full Text] [Related]
32. Potential Therapeutic Action of Adiponectin in Duchenne Muscular Dystrophy.
Abou-Samra M; Boursereau R; Lecompte S; Noel L; Brichard SM
Am J Pathol; 2017 Jul; 187(7):1577-1585. PubMed ID: 28463682
[TBL] [Abstract][Full Text] [Related]
33. Laminin-111 protein therapy enhances muscle regeneration and repair in the GRMD dog model of Duchenne muscular dystrophy.
Barraza-Flores P; Fontelonga TM; Wuebbles RD; Hermann HJ; Nunes AM; Kornegay JN; Burkin DJ
Hum Mol Genet; 2019 Aug; 28(16):2686-2695. PubMed ID: 31179490
[TBL] [Abstract][Full Text] [Related]
34. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment.
González-Sánchez J; Sánchez-Temprano A; Cid-Díaz T; Pabst-Fernández R; Mosteiro CS; Gallego R; Nogueiras R; Casabiell X; Butler-Browne GS; Mouly V; Relova JL; Pazos Y; Camiña JP
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1063-1078. PubMed ID: 30216693
[TBL] [Abstract][Full Text] [Related]
35. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
36. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.
Zhang P; He J; Wang F; Gong J; Wang L; Wu Q; Li W; Liu H; Wang J; Zhang K; Li M; Huang X; Pu C; Li Y; Jiang F; Wang F; Min J; Chen X
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):557-573. PubMed ID: 30884219
[TBL] [Abstract][Full Text] [Related]
37. Characterization and Functional Analysis of Extracellular Vesicles and Muscle-Abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 Myocytes and mdx Mice.
Matsuzaka Y; Tanihata J; Komaki H; Ishiyama A; Oya Y; Rüegg U; Takeda SI; Hashido K
PLoS One; 2016; 11(12):e0167811. PubMed ID: 27977725
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse.
McCarthy JJ; Esser KA; Andrade FH
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C451-7. PubMed ID: 17459947
[TBL] [Abstract][Full Text] [Related]
40. [Regeneration capacity of skeletal muscle].
Wernig A
Ther Umsch; 2003 Jul; 60(7):383-9. PubMed ID: 12956031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
